Detalhe da pesquisa
1.
Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment.
Haematologica
; 108(12): 3418-3432, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439373
2.
In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction.
Am J Hematol
; 98(7): 1017-1028, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971592
3.
In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction.
bioRxiv
; 2023 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36824724
4.
Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients, as a function of therapeutic transfusion and hydroxyurea treatment.
bioRxiv
; 2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066337
5.
Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.
Cell Rep
; 29(7): 1893-1908.e4, 2019 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722205